Zynerba Pharmaceuticals Stock Price - ZYNE

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 8.05 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Zynerba Pharmaceuticals Inc ZYNE NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.31 -3.71% 8.05 8.47 7.8151 8.37 8.36 00:00:08
Bid Price Ask Price Spread Spread % News
7.85 8.07 0.22 2.73% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,561 401,319 $ 8.14 $ 3,266,149 940,570 2.75 - 16.47
Last Trade Time Type Quantity Stock Price Currency
18:11:48 25 $ 8.00 USD

Zynerba Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 186.74M 23.20M $ -39.91M -2.67 - 21.06M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 7.00 9.20%

more financials information »

Zynerba Pharmaceuticals News

Loading Messages....

Latest ZYNE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ZYNE Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week7.558.487.367.9088453k0.56.62%
1 Month8.348.486.837.7857662k-0.29-3.48%
3 Months11.0212.516.839.7634842k-2.97-26.95%
6 Months8.1216.476.8311.97902M-0.07-0.86%
1 Year7.416.472.759.75581M0.658.78%
3 Years11.5525.952.7510.7393767k-3.5-30.30%
5 Years18432.7510.9357603k-9.95-55.28%

Zynerba Pharmaceuticals Description

Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates are ZYN001 and ZYN002. The company has initiated a clinical trial for both the product candidates.

Your Recent History
Zynerba Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.